Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jan 8 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 350,000 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 41,250 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 28,675 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 38,234 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 85,391 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 400,000 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 41,250 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 28,675 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 38,234 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 85,391 | — | — | — | Open the original filing on SEC.gov |